Zhongqiu Liu Selected Research

pubescenoside A

1/2021

Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongqiu Liu Research Topics

Disease

49	Neoplasms (Cancer) 03/2024 - 04/2008
21	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2007
17	Inflammation (Inflammations) 04/2024 - 05/2008
11	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2016
9	Rheumatoid Arthritis 12/2023 - 01/2014
9	Carcinogenesis 02/2022 - 05/2016
7	Neoplasm Metastasis (Metastasis) 03/2024 - 05/2016
7	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2014
6	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 06/2017
6	Colonic Neoplasms (Colon Cancer) 11/2023 - 06/2017
5	Arthritis (Polyarthritis) 12/2023 - 01/2017
5	Pain (Aches) 11/2023 - 01/2021
4	Fibrosis (Cirrhosis) 01/2024 - 01/2020
4	Cardiotoxicity 09/2023 - 01/2019
4	Reperfusion Injury 12/2022 - 10/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2016
4	Osteoarthritis 01/2022 - 01/2017
3	Diarrhea 11/2023 - 01/2019
3	Myocardial Infarction 11/2023 - 10/2020
3	Poisoning 09/2023 - 08/2013
3	Heart Failure 07/2023 - 01/2022
3	Neuroinflammatory Diseases 01/2023 - 09/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022 - 10/2020
3	Liver Neoplasms (Liver Cancer) 04/2022 - 10/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2020
2	Thromboangiitis Obliterans (Buerger's Disease) 04/2024 - 10/2023
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 01/2021
2	Colitis 11/2023 - 12/2022
2	Abdominal Obesity 07/2023 - 01/2020
2	Kidney Calculi (Kidney Stone) 04/2023 - 10/2022
2	Wounds and Injuries (Trauma) 01/2023 - 01/2014
2	Cholestasis 01/2023 - 01/2021
2	COVID-19 12/2022 - 08/2020
2	Infarction (Infarctions) 12/2022 - 10/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2022 - 01/2020
2	Cough 06/2022 - 01/2015
2	Leukemia 01/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2007
13	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2017
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 08/2012
7	AlkaloidsIBA 09/2023 - 05/2008
6	FlavonoidsIBA 11/2023 - 09/2010
6	Therapeutic UsesIBA 11/2023 - 06/2017
5	Analgesics (Analgesic Drugs)IBA 03/2023 - 01/2017
5	EnzymesIBA 08/2022 - 12/2015
5	Multidrug Resistance-Associated Protein 2IBA 01/2019 - 08/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2019
4	AntioxidantsIBA 10/2023 - 02/2019
4	LipidsIBA 02/2023 - 01/2022
4	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2021
4	kaempferolIBA 12/2022 - 01/2018
4	LigandsIBA 12/2022 - 11/2018
4	ArtesunateIBA 01/2022 - 05/2016
4	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2020 - 01/2016
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2024 - 01/2022
3	LipopolysaccharidesIBA 12/2023 - 03/2023
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 03/2021
3	InflammasomesIBA 01/2023 - 01/2021
3	VaccinesIBA 12/2022 - 12/2021
3	AntibodiesIBA 12/2022 - 12/2019
3	Histones (Histone)IBA 04/2022 - 12/2020
3	Histone MethyltransferasesIBA 04/2022 - 12/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2015
3	Multidrug Resistance-Associated ProteinsIBA 12/2018 - 12/2012
3	GlucuronidesIBA 12/2018 - 01/2016
3	Protein Isoforms (Isoforms)IBA 01/2016 - 02/2013
2	Troleandomycin (TAO)FDA Link 04/2024 - 10/2023
2	CateninsIBA 03/2024 - 05/2016
2	NF-kappa B (NF-kB)IBA 02/2024 - 02/2022
2	formononetinIBA 12/2023 - 01/2023
2	Insulin (Novolin)FDA Link 12/2023 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 01/2023
2	LuteolinIBA 12/2023 - 11/2023
2	Dextran SulfateIBA 11/2023 - 12/2022
2	shosaiko-to (TJ9)IBA 11/2023 - 01/2019
2	Cytochrome P-450 CYP3AIBA 09/2023 - 03/2015
2	ApigeninIBA 07/2023 - 01/2020
2	OxalatesIBA 04/2023 - 10/2022
2	fuzi drug herbalIBA 03/2023 - 05/2008
2	Acetic Acid (Vinegar)FDA LinkGeneric 03/2023 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2022
2	Complement System Proteins (Complement)IBA 12/2022 - 12/2021
2	Conjugate VaccinesIBA 12/2022 - 12/2021
2	Glycoproteins (Glycoprotein)IBA 12/2022 - 12/2021
2	Cancer VaccinesIBA 12/2022 - 12/2021
2	Phosphotransferases (Kinase)IBA 06/2022 - 02/2022
2	dioscinIBA 06/2022 - 10/2017
2	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2017
2	Lysine (L-Lysine)FDA Link 01/2022 - 12/2020
2	sinomenineIBA 03/2021 - 01/2017
2	AconitineIBA 01/2021 - 01/2014
2	MethyltransferasesIBA 12/2020 - 12/2016

Therapy/Procedure

8	Therapeutics 10/2022 - 12/2016
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 01/2014
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2020
3	Chemoprevention 06/2019 - 09/2010
2	Immunotherapy 01/2022 - 12/2019